REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Glucosamina S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Glucosamina S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Glucosamina S.A. is based in Ecuador, with the head office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 04, 2006. Glucosamina S.A. currently employs 1 (2022) people. In 2022, the company reported a net sales revenue increase of 11.27%. There was a total negative growth of 16.98% in Glucosamina S.A.’s total assets over the same period. The enterprise’s net profit margin increased by 24.87% in 2022.

Headquarters
Av. Amazonas N39-185, Jimenez Bldg. , Floor 4
Quito; Pichincha;

Contact Details: Purchase the Glucosamina S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Glucosamina S.A. report to view the information.
Outstanding Shares:
Purchase the Glucosamina S.A. report to view the information.
Registered Capital:
Purchase the Glucosamina S.A. report to view the information.
Incorporation Date:
April 04, 2006
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Glucosamina S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
11.27%▲
Total operating revenue
12.82%▲
Operating profit (EBIT)
1009.12%▲
Net Profit (Loss) for the Period
1009.85%▲
Total assets
-16.98%▼
Total equity
970.83%▲
Operating Profit Margin (ROS)
40.3%▲
Net Profit Margin
24.87%▲
Return on Equity (ROE)
3.5%▲
Quick Ratio
1.19%▲
Cash Ratio
0.48%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo